Abstract
Fulminant liver failure due to visceral leishmaniais is very rare, and has been described only in children. We report an immunocompetent adult man who developed acute liver failure due to leishmaniais and dramatically recovered with amphotericin-B therapy.
MeSH terms
-
Adult
-
Amphotericin B / therapeutic use*
-
Antiprotozoal Agents / therapeutic use*
-
Humans
-
Immunocompetence
-
Leishmaniasis, Visceral / complications*
-
Leishmaniasis, Visceral / drug therapy*
-
Liver Failure, Acute / parasitology*
-
Male
-
Treatment Outcome
Substances
-
Antiprotozoal Agents
-
Amphotericin B